Z, F., LC, Y., YQ, C., WQ, W., HR, M., LH, Y., . . . XL, Z. (2026). Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter Cohort. Pharmacoepidemiology and drug safety, 35(6), e70390. https://doi.org/10.1002/pds.70390
Chicago Style (17th ed.) CitationZ, Fan, et al. "Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter Cohort." Pharmacoepidemiology and Drug Safety 35, no. 6 (2026): e70390. https://doi.org/10.1002/pds.70390.
MLA (9th ed.) CitationZ, Fan, et al. "Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter Cohort." Pharmacoepidemiology and Drug Safety, vol. 35, no. 6, 2026, p. e70390, https://doi.org/10.1002/pds.70390.